BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,477,861 | -17.6% | 39,159 | -0.5% | 0.02% | -4.8% |
| Q2 2023 | $1,793,196 | +12.9% | 39,359 | +0.5% | 0.02% | +5.0% |
| Q1 2023 | $1,588,289 | -19.8% | 39,159 | +0.7% | 0.02% | -23.1% |
| Q4 2022 | $1,981,459 | -4.3% | 38,875 | +1.1% | 0.03% | -10.3% |
| Q3 2022 | $2,071,000 | -16.7% | 38,458 | -0.7% | 0.03% | -23.7% |
| Q2 2022 | $2,486,000 | -20.1% | 38,712 | -3.6% | 0.04% | +18.8% |
| Q1 2022 | $3,113,000 | -10.7% | 40,152 | -1.1% | 0.03% | -15.8% |
| Q4 2021 | $3,486,000 | +2.9% | 40,605 | -3.6% | 0.04% | -2.6% |
| Q3 2021 | $3,387,000 | -0.6% | 42,105 | -0.5% | 0.04% | +2.6% |
| Q2 2021 | $3,408,000 | -4.5% | 42,330 | 0.0% | 0.04% | -9.5% |
| Q1 2021 | $3,570,000 | -4.7% | 42,330 | -9.4% | 0.04% | -14.3% |
| Q4 2020 | $3,747,000 | -56.8% | 46,697 | -56.7% | 0.05% | -61.7% |
| Q3 2020 | $8,672,000 | -12.8% | 107,830 | -6.6% | 0.13% | -12.9% |
| Q2 2020 | $9,945,000 | +155.9% | 115,509 | +141.3% | 0.15% | +119.4% |
| Q1 2020 | $3,887,000 | -4.8% | 47,876 | -2.0% | 0.07% | +17.5% |
| Q4 2019 | $4,083,000 | -2.4% | 48,833 | +2.1% | 0.06% | +3.6% |
| Q3 2019 | $4,184,000 | -1.6% | 47,838 | -7.9% | 0.06% | -5.2% |
| Q2 2019 | $4,253,000 | +1.3% | 51,927 | +0.6% | 0.06% | -1.7% |
| Q1 2019 | $4,198,000 | +18.1% | 51,630 | -4.4% | 0.06% | +5.4% |
| Q4 2018 | $3,556,000 | -14.5% | 54,020 | +0.1% | 0.06% | -1.8% |
| Q3 2018 | $4,161,000 | +3.9% | 53,976 | -0.5% | 0.06% | -3.4% |
| Q2 2018 | $4,006,000 | -45.4% | 54,259 | -51.9% | 0.06% | -46.8% |
| Q1 2018 | $7,334,000 | -50.6% | 112,767 | -51.7% | 0.11% | -4.3% |
| Q4 2017 | $14,859,000 | +95.5% | 233,412 | +92.7% | 0.12% | -5.7% |
| Q3 2017 | $7,599,000 | +4.6% | 121,096 | +0.9% | 0.12% | 0.0% |
| Q2 2017 | $7,262,000 | -2.8% | 119,961 | -16.7% | 0.12% | -15.8% |
| Q1 2017 | $7,471,000 | +12.7% | 144,061 | -3.7% | 0.15% | +6.6% |
| Q4 2016 | $6,632,000 | +2.0% | 149,561 | +9.5% | 0.14% | -2.1% |
| Q3 2016 | $6,500,000 | +8.2% | 136,553 | +2.7% | 0.14% | +4.5% |
| Q2 2016 | $6,010,000 | +17.4% | 132,913 | +6.7% | 0.13% | +14.5% |
| Q1 2016 | $5,119,000 | +30.7% | 124,621 | +21.3% | 0.12% | +27.2% |
| Q4 2015 | $3,918,000 | +16.5% | 102,699 | +0.3% | 0.09% | +9.5% |
| Q3 2015 | $3,364,000 | -52.2% | 102,399 | +1.7% | 0.08% | -48.5% |
| Q2 2015 | $7,043,000 | +5.0% | 100,717 | +2.9% | 0.16% | +4.5% |
| Q1 2015 | $6,707,000 | -5.3% | 97,917 | +1.3% | 0.16% | -6.6% |
| Q4 2014 | $7,081,000 | +4.7% | 96,617 | +2.6% | 0.17% | -0.6% |
| Q3 2014 | $6,760,000 | +0.9% | 94,185 | +1.6% | 0.17% | +0.6% |
| Q2 2014 | $6,701,000 | -17.9% | 92,685 | -16.4% | 0.17% | -21.6% |
| Q1 2014 | $8,159,000 | +7.9% | 110,885 | +2.0% | 0.21% | +6.0% |
| Q4 2013 | $7,559,000 | +60.3% | 108,685 | +51.4% | 0.20% | +4.7% |
| Q3 2013 | $4,716,000 | -4.2% | 71,785 | +1.0% | 0.19% | -9.0% |
| Q2 2013 | $4,922,000 | – | 71,055 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |